StockpollyBeta
Get App
Popularity #1,105
HSIC · NASDAQ · Medical - Distribution

Henry Schein (HSIC)

Distributes clinical supplies and equipment alongside specialty products and practice software.

$86.15
vs last close−1.28 (−1.47%)

  1. Here's Why Henry Schein (HSIC) is a Strong Growth Stock

    Zacks Investment Research

  2. Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher

    Seeking Alpha

  3. Are Investors Undervaluing Henry Schein (HSIC) Right Now?

    Zacks Investment Research

  4. What Makes Henry Schein (HSIC) a New Buy Stock

    Zacks Investment Research

  5. HSIC or SAUHY: Which Is the Better Value Stock Right Now?

    Zacks Investment Research

  6. Here's Why Henry Schein (HSIC) is a Strong Value Stock

    Zacks Investment Research

  7. Henry Schein: Growth Is Improving, But The Valuation Stays Cheap

    Seeking Alpha

  8. Henry Schein, Inc. (HSIC) Presents at 2026 Global Healthcare Conference Transcript

    Seeking Alpha

  9. Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?

    Zacks Investment ResearchMarket move

  10. 505,999 Shares in Henry Schein, Inc. $HSIC Purchased by Bank of New York Mellon Corp

    Defense WorldOwnership

  11. HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates

    Zacks Investment ResearchGuidance

  12. Empowered Funds LLC Has $851,000 Position in Henry Schein, Inc. $HSIC

    Defense WorldOwnership

  13. Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?

    Zacks Investment Research

  14. Here's Why Henry Schein (HSIC) is a Strong Momentum Stock

    Zacks Investment Research

  15. Should Value Investors Buy Henry Schein (HSIC) Stock?

    Zacks Investment Research

  16. HSIC or SAUHY: Which Is the Better Value Stock Right Now?

    Zacks Investment Research

  17. Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?

    Zacks Investment Research

  18. Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript

    Seeking Alpha

  19. Henry Schein Q2 Earnings Call Highlights

    MarketBeat

  20. HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs

    Zacks Investment Research

  21. Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say

    Zacks Investment Research

  22. Henry Schein (HSIC) Q2 Earnings and Revenues Beat Estimates

    Zacks Investment Research

  23. Did Henry Schein Inc (HSIC) Just Beat EPS Estimates with Q2 Earnings? GF Score: 81/100, 2.7% Overvalued

    GuruFocus

  24. Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance

    Business Wire